Yining Xu

1.5k total citations
31 papers, 1.2k citations indexed

About

Yining Xu is a scholar working on Pharmaceutical Science, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yining Xu has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmaceutical Science, 10 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yining Xu's work include Advanced Drug Delivery Systems (14 papers), Drug Solubulity and Delivery Systems (5 papers) and RNA Interference and Gene Delivery (5 papers). Yining Xu is often cited by papers focused on Advanced Drug Delivery Systems (14 papers), Drug Solubulity and Delivery Systems (5 papers) and RNA Interference and Gene Delivery (5 papers). Yining Xu collaborates with scholars based in Belgium, China and United Kingdom. Yining Xu's co-authors include Ana Beloqui, Véronique Préat, Neha Shrestha, Yuan Huang, Jing Wu, Y. C. Huang, Ke Cao, Jiangang Zou, Zhao-Jun Wang and Xi Zhu and has published in prestigious journals such as ACS Nano, Biomaterials and Endocrine Reviews.

In The Last Decade

Yining Xu

28 papers receiving 1.2k citations

Peers

Yining Xu

BIOMA

SURGE

Tingting Fan China

Xianggen Wu China

Kuan Yau Wong Australia

Bhavin Vyas India

Wessam M. El-Refaie Egypt

Lucia Ruxandra Tefas Romania

Yingjie Zhai China

Vieri Piazzini Italy

Dhanalekshmi Unnikrishnan Meenakshi India

Meng‐Lei Huan China

Tingting Fan China

Yining Xu

223 ×0.5

919 ×2.1

111 ×0.5

BIOMA

113 ×0.8

70 ×0.6

SURGE

Citations per year, relative to Yining Xu Yining Xu (= 1×) peers Tingting Fan

Countries citing papers authored by Yining Xu

Since Specialization

Citations

This map shows the geographic impact of Yining Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yining Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yining Xu more than expected).

Fields of papers citing papers by Yining Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yining Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yining Xu. The network helps show where Yining Xu may publish in the future.

Co-authorship network of co-authors of Yining Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yining Xu. A scholar is included among the top collaborators of Yining Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yining Xu. Yining Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Yining, Daniel J. Drucker, Giovanni Traverso, & Ana Beloqui. (2025). Innovative Molecules and Delivery Technologies Enabling the Future of GLP-1-based Therapies. Endocrine Reviews. 47(1). 1–23. 1 indexed citations

Huang, Yuan, et al.. (2025). Advances in Oral Biomacromolecule Therapies for Metabolic Diseases. Pharmaceutics. 17(2). 238–238. 2 indexed citations

Chen, Cheng, et al.. (2025). An antioxidant metal-organic framework with functional coatings for oral anti-TNF-α antibody delivery in inflammatory bowel disease treatment. Journal of Controlled Release. 389. 114411–114411.

Wang, Yu, Cheng Chen, Xin Xiao, et al.. (2025). Advanced oral therapies for colorectal cancer via nanomedicine and microbiota modulation. Advanced Drug Delivery Reviews. 228. 115741–115741.

Xu, Yining, Hongyi Jiang, Wen Zeng, et al.. (2025). CDK8 mediated inflammatory microenvironment aggravates osteoarthritis progression. Journal of Advanced Research. 77. 585–603. 6 indexed citations

McCartney, Fiona, Yining Xu, Inês Domingues, et al.. (2024). An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragment to treat inflammatory bowel disease. Journal of Controlled Release. 374. 254–266. 6 indexed citations

Yang, Fan, Beibei Wu, Jiahao Chen, et al.. (2024). Photo-controlled multifunctional hydrogel for photothermal sterilization and microenvironment amelioration of infected diabetic wounds. Journal of Controlled Release. 377. 470–484. 6 indexed citations

Xu, Yining, Tamana Darwish, Constanza Alcaino, et al.. (2024). Smart control lipid-based nanocarriers for fine-tuning gut hormone secretion. Science Advances. 10(50). eadq9909–eadq9909. 3 indexed citations

Chen, Cheng, Ana Beloqui, & Yining Xu. (2023). Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease. Advanced Drug Delivery Reviews. 203. 115117–115117. 22 indexed citations

10.

Xu, Yining, Inês Domingues, Tom G. Moreels, et al.. (2023). A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment. Bioactive Materials. 32. 206–221. 23 indexed citations

11.

Xu, Yining, Neha Shrestha, Véronique Préat, & Ana Beloqui. (2021). An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers. Advanced Drug Delivery Reviews. 175. 113795–113795. 107 indexed citations

12.

Shrestha, Neha, Yining Xu, Fiona McCartney, et al.. (2021). Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease. Acta Biomaterialia. 140. 561–572. 39 indexed citations

13.

Xu, Yining, Herlinde De Keersmaecker, Kevin Braeckmans, et al.. (2020). Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment. Biomaterials. 255. 120209–120209. 41 indexed citations

14.

Xu, Yining, Neha Shrestha, Véronique Préat, & Ana Beloqui. (2020). Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems. Journal of Controlled Release. 322. 486–508. 158 indexed citations

15.

Xu, Yining, et al.. (2020). Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis. International Journal of Pharmaceutics. 586. 119515–119515. 50 indexed citations

16.

Lin, Yao, Fanyuan Yu, Yining Xu, et al.. (2019). DNA damage response manages cell cycle restriction of senile multipotent mesenchymal stromal cells. Molecular Biology Reports. 47(1). 809–818. 3 indexed citations

17.

Xu, Juan, Chong Liu, Yining Xu, et al.. (2015). [Mechanism of cellular uptake and transport mediated by integrin receptor targeting trimethyl chitosan nanoparticles].. PubMed. 50(7). 893–8. 2 indexed citations

18.

Liu, Chong, Wei Shan, Min Liu, et al.. (2015). A novel ligand conjugated nanoparticles for oral insulin delivery. Drug Delivery. 23(6). 2015–2025. 45 indexed citations

19.

Zhang, Peiwen, Yining Xu, Xi Zhu, & Yuan Huang. (2015). Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin. International Journal of Pharmaceutics. 496(2). 993–1005. 66 indexed citations

20.

Eichenbaum, Gary, Joe Nguyen, Herman Borghys, et al.. (2006). Preclinical Assessment of the Feasibility of Applying Controlled Release Oral Drug Delivery to a Lead Series of Atypical Antipsychotics. Journal of Pharmaceutical Sciences. 95(4). 883–895. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact